Variable | Pancreatic duct obstruction after pancreaticojejunostomy | P value | |
---|---|---|---|
Present (n = 25) | Absent (n = 53) | ||
Mean age at operation, y | 54.6±16.1 (range -) | 56.7±16.1 (range 14-79) | 0.712 |
Sex, M:F (%) | 17 (68):8 (32) | 30 (57):23 (43) | 0.458 |
Pancreatic duct diameter (mm) | |||
Before operation | 0.153 | ||
Mean ± SD | 3.5 ± 2.4 | 3.0 ± 1.9 | |
Median [range] | 2.5 [1.0-10.0] | 2.8 [1.0-9.0] | |
After operation | 0.000 | ||
Mean ± SD | 5.7 ± 2.6 | 1.8 ± 0.6 | |
Median [range] | [3.3-13.0] | [1.0-3.0] | |
Pancreatic parenchymal thickness (mm) | |||
Before operation | 0.870 | ||
Mean ± SD | 14.0 ± 4.9 | 14.3 ± 5.7 | |
Median [range] | 18 [10.7-25.0] | 17.4 [4.5-30.0] | |
After operation | |||
Mean ± SD | 9.5 ± 4.1 | 14.1 ± 4.9 | 0.000 |
Median [range] | 11 [2.5-16.7] | 14.7 [3.0-28.3] | |
Type of operation, n (%) | 1.000 | ||
Pancreaticoduodenectomy | 24 | 49 | |
Segment resection of pancreas* | 1 | 4 | |
Pancreatic duct stent retained > 2 years, n (%) | 1 (4) | 9 (17) | 0.155 |
Adjuvant therapy, n (%) | 9 (36) | 11 (21) | 0.397 |
I125 radioactive seeds implantation, n (%) | 2 (8) | 1 (2) | 0.245 |
Pancreatic fistula, n (%) | 3 (12) | 14 (26) | 0.240 |
Malignant tumor, n (%) | 13 (52) | 30 (57) | 0.809 |
Follow-up period (mo) | 0.551 | ||
Mean ± SD | 39.8 ± 20.4 | 37.1 ± 22.0 |